Analyst Reco. Novo Nordisk A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:54 2024-04-19 am EDT			After market 11:20:00 am
866.2 ^DKK	+0.41%		866.4	+0.02%

Apr. 18	India's Biocon developing its own version of Wegovy, clinical trial likely next year	RE
Apr. 15	More than 250 websites selling fake weight-loss drugs reported by anti-counterfeit firm	RE

BMO Capital Starts Novo Nordisk With Outperform Rating, $163 Price Target	Apr. 12	MT
NOVO NORDISK : UBS sticks Neutral	Mar. 26	ZD
NOVO NORDISK : Barclays maintains a Buy rating	Mar. 25	ZD
NOVO NORDISK : Berenberg remains Neutral	Mar. 18	ZD
NOVO NORDISK : Novo’s bag is full of pearls!	Mar. 15
NOVO NORDISK : Barclays reiterates its Buy rating	Mar. 11	ZD
NOVO NORDISK : UBS sticks Neutral	Mar. 11	ZD
NOVO NORDISK : JP Morgan reaffirms its Buy rating	Mar. 08	ZD
NOVO NORDISK : Deutsche Bank reiterates its Buy rating	Mar. 08	ZD
NOVO NORDISK : Novo’s got a strong arsenal to go the distance	Mar. 08
NOVO NORDISK : Buy rating from Barclays	Mar. 07	ZD
NOVO NORDISK : Receives a Buy rating from Deutsche Bank	Mar. 06	ZD
NOVO NORDISK : JP Morgan reiterates its Buy rating	Mar. 05	ZD
NOVO NORDISK : UBS reiterates its Neutral rating	Mar. 05	ZD
NOVO NORDISK : Receives a Buy rating from Deutsche Bank	Mar. 01	ZD
NOVO NORDISK : Receives a Buy rating from Deutsche Bank	Feb. 28	ZD
NOVO NORDISK : UBS reiterates its Neutral rating	Feb. 27	ZD
NOVO NORDISK : Berenberg sticks Neutral	Feb. 27	ZD
NOVO NORDISK : Berenberg remains Neutral	Feb. 27	ZD
NOVO NORDISK : Deutsche Bank reaffirms its Buy rating	Feb. 27	ZD